what does epithalon do Epithalon Peptide Therapy in Scottsdale

Even the individual compound data becomes thinner at longer timeframes

It raises questions for post-operative vascular surgery and disorders of venous return

These unknowns do not invalidate the existing safety data

Most published information currently comes from: While many findings appear promising, additional research is needed to better understand long-term safety, effectiveness, dosing protocols, and potential risks in diverse patient populations

The FDAs stated concerns are: (1) theoretical risk of allergic reactions with repeated peptide administration, (2) quality control concerns about compounding purity and consistency, and (3) no Phase 1-3 trials conducted under FDA oversight